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Renal cell carcinoma in a transplant kidney is a rare condition. Nephron Sparing Surgery (NSS) is the
treatment of choice. One of the main technical challenges is obtaining adequate vascular control. We
present a rare case of large centrally located hillar tumor in a kidney 18 years after transplantation
treated with NSS. Vascular control was achieved by using a novel approach. Post-operative course was
uneventful with minimal decrease in renal function. We believe that this unique choice of treatment can
be used in cases of NSS where the access to the renal pedicle is limited.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Renal cell carcinomas (RCC) comprise 4.6% of malignant neo-
plasms in patients following kidney transplantation occurs more
frequently than in the general population. Native kidneys are
affected in 90% of cases compared with 10% of the transplanted
kidneys. Thus the incidence of RCC in transplant kidney is
extremely low (0.18).1e3
Like in native kidneys these tumors are usually asymptomatic
and diagnosed following routine imaging studies. Nephron Sparing
Surgery (NSS) is the treatment of choice, although graft nephrec-
tomy is chosen in cases with large lesion (>40 mm), decreased
functioning graft, and locally advanced disease.1e3 For small and
exophytic lesions ablative strategy may be also used.4 One of the
main technical challenges is obtaining adequate vascular control.
Hereinwe present a case of large centrally located hilar tumor in
a kidney 18 years after transplantation.Case report
A 38-year-old male patient with history of end stage chronic
renal failure caused by membranous nephropathy diagnosed inBnai Zion Medical Center,
.
Inc. This is an open access article uchildhood. The patient received a living donor kidney transplant
from his mother at the age of 20 years. Immunosuppressive treat-
ment consisted of: Prednison, Mycophenolate mofetil, and Cyclo-
sporin A. Recently a routine follow-up sonographic scan revealed a
mass in the transplanted kidney. A CT scan demonstrated a large
enhancing solid central mass in the hilar region of the kidneyFigure 1. CT scan of the abdomen demonstrating a large solid enhancing central mass
in the hilar region of the kidney located in the right iliac fossa measuring,
6.3  6.7  5.9 cm.
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. Arterial catheterization of the transplant renal artery and placement of an
occlusion balloon catheter (arrow).
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normal and baseline serum creatinine was 1.7 mg/dL.
NSS was the chosen procedure due to patient young age and his
wish to avoid renal replacement treatment. Tunneled dialysis
catheter (HemoFlow HFS28E, Medcomp, Germany) was inserted
prior to surgery in case of post-operative need for dialysis.
Considering possible difﬁculties in approaching the renal pedicle
due to adhesions and the location of the tumor, arterial catheter-
ization of the Iliac artery was performed in the operating room
prior to surgery and an arterial occlusion balloon catheter
(LeMaitre 5Fr. Plus, LeMaitre Vascular, USA) was inserted into the
renal transplant artery via a contra lateral femoral approach
(Fig. 2) in order to ensure adequate hemostatic control without the
need to expose and clamp the friable renal artery. Under general
anesthesia, through the previous right lower abdominal trans-
plant’s incision the kidney was exposed and freed from the sur-
rounding structures, the ureter was identiﬁed and then the
arterial balloon located in the transplant artery was inﬂated.
Surface cooling was achieved with ice slush and the lesion wasFigure 3. Pathology of the resected specimen demonstrating combined papillaenucleated intact and opening of the collecting system as well as
exposed blood vessels were individually sutured. Tumor bed
closure was carried out with 15 mL of BioGlue tissue adhesive.
Renal artery was occluded for 54 min under in situ cooling con-
ditions. After the enucleation the arterial balloon was deﬂated. No
signs of bleeding or urinary extravasations were seen. Post-
operative course was uneventful. No hemodialysis was required,
patient creatinine level after the surgery was elevated up to
2.9 mg/dL from basal creatinine of 1.7 mg/dL, but gradually
decreased to level of 2.1 mg/dL.
Pathology revealed combined papillary type II, grade 3 and clear
cell type, grade 3 renal cell carcinoma (Fig. 3).
Discussion
The risk for developing RCC in renal transplant patients is 7e10
times higher than in general population, however only 10% of
those tumors are in the transplanted kidney. These tumors are
considered de novo neoplasm mainly because their average time
of diagnosis after transplantation is 5 years. These tumors are
usually small, low grade with relatively good prognosis. More than
half of them are papillary type and most of the rest are clear Cell.
Treatment options include nephrectomy, NSS, ablation and
observation. NSS is usually performedwhen the lesion is small and
in peripheral location. The preference in choosing this procedure
is usually to keep patient off dialysis. The patient presented is
young with a large, centrally located lesion.1e3 Despite the
complexity of the lesion, we elected to perform NSS in order to
avoid hemodialysis and maintain his good quality of life. Technical
concerns before surgery included the limited ability to expose
properly the kidney hilum and clamp the renal artery, the
expected high complication rate due to tumor size and central/
hilar location combined with possible adhesions of the kidney and
ureter to the surrounding organs made the exposure in doubt. In
order to avoid unnecessary manipulation of the renal artery we
elected to use a novel approach to achieve temporary arterial
occlusion and bloodless ﬁeld while dissecting the tumor. Through
a contra lateral femoral artery catheterization an angiography
team selectively catheterized the transplant renal artery and
placed an occlusion balloon catheter. Before surface cooling and
removal of the mass this balloon was inﬂated resulting in
decreased turgor of the kidney, minimal bleeding, and excellent
visibility without vascular damage at the anastomotic area.
Another point for consideration was the preoperative impaired
renal function that makes the kidney more vulnerable to the
ischemia reperfusion injury associated with vascular clamping. We
inserted prior to surgery a hemodialysis access catheter in casery type II, grade 3 (A) and clear cell type, grade 3 (B) renal cell carcinoma.
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Manitol (0.5 g/kg body weight) was given prior to renal artery
occlusion and surface cooling of the kidney was applied in order to
reduce the metabolic needs of the kidney during the ischemic
period. Except for closing the opened collecting system with
monocryl 4/0 continues suture tumor bed was closed with tissue
adhesive only reducing the amount of lost functioning tissue that is
associated when tumor bed is closed with sutures. Based on pre-
vious reports that have shown decreased kidney injury following
clamping of the renal artery alone compared with vascular control
of the artery and vein,5 we elected to leave the transplant renal vein
open.
In summary, we report an unusual case of renal cell carcinoma in
transplanted kidney managed by NSS despite the lesion high renal
score. A novel approach was used to achieve vascular control by
using intra arterial balloon catheterization prior to surgery. We
believe that this unique choice of treatment can be used in cases of
NSS where the access to the renal pedicle is limited.Disclosure
The authors of this manuscript have no conﬂict of interest to
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